ORI
NVRO

Oak Ridge Investments’s NEVRO CORP. NVRO Stock Holding History

Oak Ridge Investments’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-229,608
Closed -$18.3M – 165
2018
Q2 		$18.3M Sell
229,608
-19,065
-8% -$1.58M 1.04% 29
2018
Q1 		$21.6M Sell
248,673
-60,146
-19% -$4.86M 1.2% 25
2017
Q4 		$21.3M Sell
308,819
-74,428
-19% -$5.95M 1.02% 35
2017
Q3 		$34.8M Sell
383,247
-165,688
-30% -$14.2M 1.41% 20
2017
Q2 		$40.9M Buy
548,935
+15,952
+3% +$1.28M 1.3% 27
2017
Q1 		$49.9M Buy
532,983
+92,165
+21% +$8.35M 1.68% 19
2016
Q4 		$32M Sell
440,818
-32,122
-7% -$2.75M 1.04% 40
2016
Q3 		$49.4M Sell
472,940
-60,424
-11% -$5.46M 1.28% 29
2016
Q2 		$39.3M Sell
533,364
-11,226
-2% -$762K 1.01% 41
2016
Q1 		$30.6M Buy
544,590
+149,954
+38% +$8.85M 0.77% 45
2015
Q4 		$26.6M Buy
394,636
+1
+0% +$54 0.64% 47
2015
Q3 		$18.3M Sell
394,635
-676
-0.2% -$32.8K 0.44% 68
2015
Q2 		$21.2M Buy
395,311
+268,273
+211% +$13.7M 0.45% 62
2015
Q1 		$6.09M Buy
+127,038
New +$5.51M 0.14% 112

Other funds holding NVRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Oak Ridge Investments's NVRO Position: Q3 2018 in Review

Oak Ridge Investments sold out of NEVRO CORP. (NVRO) in Q3 2018, closing a stake of 229,608 shares — an estimated $18.3M sold.

Oak Ridge Investments first reported a position in NVRO in Q1 2015 and held it in 14 quarters. The position peaked at $49.9M in Q1 2017. 171 funds tracked by Wall St. Rank hold NVRO as of Q3 2018.

  • Oak Ridge Investments reported no remaining NEVRO CORP. position as of Q3 2018 after selling out during the quarter.
  • Oak Ridge Investments sold 229,608 NEVRO CORP. shares in Q3 2018, an estimated $18.3M.
  • Oak Ridge Investments first reported a position in NEVRO CORP. in Q1 2015 and held it in 14 quarters.
  • Oak Ridge Investments's NEVRO CORP. position peaked at $49.9M in Q1 2017.
  • 171 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2018.

Based on Oak Ridge Investments's 13F filing for Q3 2018, filed 7 Nov 2018.